Skip to content
In Stock Mysoline
Epilepsy

Mysoline

Adults and children with certain seizure disorders may be prescribed Mysoline, which contains primidone. It helps reduce abnormal electrical activity in the brain and is used for generalised…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Primidone
Select pack Package Per unit Price
$ 6.23 $ 186.90
$ 4.84 $ 373.80 $ 290.14 Save 22%
Free Regular Delivery $ 4.59 $ 560.70 $ 412.96 Save 26%
Free Regular Delivery $ 4.14 $ 747.60 $ 496.62 Save 34%
Free Express Delivery $ 3.90 $ 1,121.40 $ 701.32 Save 37%
Best value Free Express Delivery $ 3.45 $ 2,242.80 $ 1,242.44 Save 45%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Adults and children with certain seizure disorders may be prescribed Mysoline, which contains primidone. It helps reduce abnormal electrical activity in the brain and is used for generalised tonic-clonic, focal, and psychomotor seizures.

Product information

Mysoline is an anticonvulsant tablet containing primidone. Neurologists may use it to manage grand mal epileptic seizures, psychomotor seizures, and focal epileptic seizures.

Ingredients

Primidone is the active ingredient in Mysoline. After oral administration, the body converts part of the dose into phenobarbital and phenylethylmalonamide, also called PEMA. Primidone itself and its metabolites contribute to anticonvulsant activity.

Metabolic Conversion Pathways

The pathway can be summarised as:

Primidone → phenobarbital + phenylethylmalonamide

Mysoline is not interchangeable with phenobarbital on a tablet-for-tablet basis. Although one metabolite is phenobarbital, the overall exposure depends on primidone absorption, conversion, elimination, and the person’s treatment schedule.

The WHO describes epilepsy as a neurological disorder involving recurrent unprovoked seizures, while clinical pharmacology references describe primidone’s conversion to phenobarbital and PEMA [2].

Therapeutic indications

Mysoline is used to manage grand mal epileptic seizures, psychomotor seizures, and focal epileptic seizures. The treatment plan depends on seizure type, age, kidney and liver function, previous medicines, and seizure control.

The term “grand mal” is an older clinical description of a generalised tonic-clonic seizure. This seizure may involve loss of consciousness, body stiffening, rhythmic jerking, and a period of confusion afterwards. A focal epileptic seizure begins in one area of the brain. Awareness may remain intact or become impaired, depending on how the abnormal electrical activity spreads.

Mysoline is used for seizure control rather than immediate rescue treatment. A person experiencing a prolonged seizure needs urgent emergency care, especially when the seizure lasts five minutes or longer, repeats without recovery, or causes breathing problems.

Management of Generalised and Focal Seizures

Clinical treatment aims to reduce seizure frequency while limiting sedation, dizziness, balance problems, and cognitive slowing. Primidone may be selected when its anticonvulsant profile fits the person’s seizure pattern and previous treatment history.

Seizure pattern Clinical description Role of primidone
Generalised tonic-clonic Loss of awareness with stiffening and rhythmic jerking May be used for long-term prevention
Focal Starts in one brain region, with or without impaired awareness May help reduce recurrent focal seizures
Psychomotor Focal seizure with altered behaviour, awareness, or memory May be included in specialist treatment

The response is measured over time. A seizure diary can help a neurologist identify missed doses, sleep deprivation, alcohol exposure, illness, and possible treatment failure.

Role in Psychomotor Seizure Control

Psychomotor seizures are now commonly described as focal impaired-awareness seizures. A person may stare, pause, perform repetitive movements, speak unusually, or remain confused for several minutes. The event can look like unusual behaviour rather than a convulsion.

Mysoline may reduce these episodes when primidone is appropriate for the individual seizure pattern. The medicine does not remove every possible trigger. Poor sleep, fever, missed doses, alcohol, and sudden withdrawal of anticonvulsant treatment can all increase seizure risk.

Record the time a seizure starts, how long it lasts, changes in awareness, movements, recovery time, and any missed dose. These details are more useful to a neurologist than a simple note saying “breakthrough seizure.”

The FDA prescribing information describes primidone as an anticonvulsant used for grand mal and psychomotor seizures, with treatment adjusted to the patient’s clinical response [1].

Directions for use

The amount taken at each intake is determined individually rather than set as one fixed number for every person. A prescriber usually starts with a low amount and increases it gradually, allowing time to assess seizure control and tolerability.

Mysoline tablets are taken by mouth. The prescribed schedule may use divided doses, and taking doses at consistent times helps maintain steadier exposure. The exact regimen depends on age, body size, seizure type, kidney and liver function, and other anticonvulsants.

Common administration principles include:

  • Take each dose at the prescribed time.
  • Swallow the tablet with water.
  • Do not double the next dose after a missed dose unless a prescriber has specifically instructed this.
  • If a dose is missed, take it when remembered unless the next scheduled dose is close.
  • Do not change the dose because seizures have improved.
  • Do not stop treatment abruptly.
  • Avoid driving or hazardous work until the effect on alertness is known.

Mysoline may be taken with food if nausea occurs. Food does not remove the need for a consistent schedule. Vomiting soon after a dose creates a separate clinical question because absorption may be incomplete.

Keep the dosing times linked to fixed daily routines, such as breakfast and bedtime, but avoid taking an extra tablet to compensate for a forgotten dose without specific instructions.

When not to use it

Mysoline is contraindicated in people with porphyria because primidone and its barbiturate-related metabolites may aggravate acute hepatic porphyrias.

  • A history of acute intermittent porphyria or another acute hepatic porphyria.
  • A previous serious allergic reaction to primidone, phenobarbital, or related anticonvulsants.
  • Severe breathing impairment that could worsen with central nervous system depression.
  • Severe liver disease requiring a different anticonvulsant strategy.
  • Severe kidney impairment requiring dose adjustment and closer monitoring.
  • Current treatment with medicines that create a clinically significant interaction.

The product information for primidone identifies porphyria as a contraindication and describes precautions involving sedation, blood disorders, liver function, and interactions [3].

When this is not for you

Mysoline should not be used without specialist assessment when you have porphyria, have previously had a serious reaction to primidone or phenobarbital, or have severe breathing, liver, or kidney problems. You should also tell the prescriber if you are taking medicines that may interact with Mysoline.

Porphyria symptoms can include severe abdominal pain, vomiting, constipation, dark urine, neurological symptoms, and psychiatric changes. A person with a known porphyria diagnosis needs a treatment plan that avoids porphyrinogenic medicines.

Mysoline also requires caution in older adults and people with a history of falls, depression, respiratory disease, or substance misuse. Alcohol and other sedatives can intensify impaired coordination and breathing suppression.

Tell the prescriber about any previous reaction to phenobarbital. The relationship between primidone and phenobarbital matters when assessing allergy history, sedation, and treatment choices.

Unwanted effects

The most common tolerability problems are related to central nervous system depression. They may be more noticeable during initiation or after an increase.

Possible effects include:

  • Drowsiness or fatigue.
  • Dizziness or vertigo.
  • Poor coordination or unsteadiness.
  • Nausea or vomiting.
  • Double vision or blurred vision.
  • Slowed thinking or difficulty concentrating.
  • Headache.
  • Mood changes or irritability.

These symptoms may improve as the body adjusts, but persistent imbalance or marked sedation needs clinical review. Falls are a real concern in older adults, especially when Mysoline is combined with alcohol, opioids, sleep medicines, or sedating antihistamines.

Rare but serious reactions include severe skin rash, facial swelling, breathing difficulty, unusual bruising, persistent fever, jaundice, severe weakness, or signs of a blood disorder. Emergency help is required for breathing difficulty, swelling of the lips or tongue, extensive blistering rash, or suicidal behaviour.

One detail patients often miss is that dizziness may be most noticeable when standing, walking downstairs, or turning quickly. The risk can remain even when the person feels mentally alert.

Another practical issue is concentration. A person who feels “fine” at home may still react more slowly in traffic or around machinery.

Mechanism of action

Phenobarbital enhances inhibitory signalling in the central nervous system. This reduces the likelihood that groups of neurons will fire in an uncontrolled, synchronised pattern. PEMA also has anticonvulsant activity, though its contribution differs between individuals.

The conversion takes place mainly through hepatic metabolism. The amount of phenobarbital produced can vary with age, liver function, dose, treatment duration, and other medicines that affect drug-metabolising enzymes.

Common mistakes

Several avoidable habits can interfere with seizure control:

  • Stopping Mysoline after a seizure-free period.
  • Taking irregular doses on weekends or during travel.
  • Doubling a missed dose.
  • Drinking alcohol while still learning how the medicine affects alertness.
  • Adding sedating supplements or sleep products without checking for interactions.
  • Driving before drowsiness and coordination effects have been assessed.
  • Failing to mention primidone when another clinician prescribes treatment.
  • Treating unusual mood changes as a normal adjustment.
  • Assuming a tablet can be substituted with phenobarbital without a new prescription.
  • Forgetting to plan doses across time-zone changes.

Comparison

Mysoline is an oral, single-ingredient anticonvulsant containing primidone; its approach differs from combination anticonvulsant treatment because it uses one active ingredient to help reduce abnormal electrical activity in the brain.

What doctors say

Neurologists generally treat Mysoline as a medicine that requires gradual dose adjustment and regular review. The goal is not simply to increase the amount until seizures stop; the clinician must balance seizure control against sedation, coordination problems, cognition, mood, and interaction risks.

Doctors also examine the reason for a breakthrough seizure. A missed dose, vomiting, sleep loss, fever, alcohol intake, a new interacting medicine, or an incorrect diagnosis can each change the treatment plan.

Drug-level testing may be considered when seizures remain uncontrolled, adverse effects are difficult to explain, adherence is uncertain, pregnancy changes pharmacokinetics, or several anticonvulsants are used together. Blood counts and liver-related tests may be requested when symptoms or treatment history justify them.

A useful clinical distinction is between an isolated seizure and a continuing pattern. One event should not automatically lead to self-directed dose escalation. Repeated events require assessment of the diagnosis, treatment exposure, and possible triggers.

What customers often ask

How does Mysoline differ from anticonvulsants with other active substances?

Mysoline contains primidone, which is metabolised partly into phenobarbital and phenylethylmalonamide. This gives it a pharmacological profile that differs from medicines acting mainly through sodium channels or calcium channels. The FDA's 2016 prescribing information describes primidone as an anticonvulsant used for several seizure types, while the WHO classifies epilepsy treatment according to seizure pattern and individual clinical needs. Treatment choice depends on seizure type, previous response, interactions, and tolerability. Clinical review remains necessary when seizure control or tolerability changes.

Can alcohol be used while taking Mysoline?

Alcohol can add to primidone-related drowsiness, dizziness, impaired balance, and slowed reactions. The risk is higher when alcohol is combined with opioids, benzodiazepines, sleep medicines, or sedating antihistamines. FDA safety information from 2016 for anticonvulsant therapy supports avoiding activities requiring full alertness until the individual response is known. Avoiding alcohol is the safer approach during dose initiation and adjustment.

How should Mysoline be stored at home and during travel?

Store the tablets in a dry place at ordinary room temperature, away from excess heat and moisture. Keep them in the dispensing container and protect them from children. During travel, keep the medicine with essential personal medicines rather than leaving it in a hot vehicle or checked luggage. Australian TGA medicine-handling guidance from 2024 supports protecting oral tablets from unsuitable heat, humidity, and accidental access.

Can Mysoline affect driving, concentration, or machinery work?

Mysoline may cause drowsiness, dizziness, blurred vision, slowed reactions, or impaired coordination. These effects can occur after starting treatment, after a dose increase, or when another sedating substance is added. The Australian TGA's 2024 medicine information addresses activities affected by impaired alertness, and the FDA also warns about central nervous system depression. Do not drive, climb, or operate machinery until the prescribed treatment has shown how it affects you.

Can Mysoline be combined with other anticonvulsants or supplements?

It may be combined with another anticonvulsant in specialist care, but primidone can alter the metabolism of other medicines and its own metabolites can contribute to sedation. Sedating supplements may intensify drowsiness, while enzyme-modifying products may change medicine exposure. The EMA product information approach from 2024 for antiseizure medicines requires interaction review when treatment is combined. Provide a complete list of medicines, hormonal contraceptives, vitamins, and herbal products before another product is added.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Sources

  1. U.S. Food and Drug Administration (2016). Mysoline (primidone) Tablets Prescribing Information.
  2. National Center for Biotechnology Information (2023). Primidone — StatPearls.
  3. Electronic Medicines Compendium (2024). Mysoline 250 mg Tablets — Summary of Product Characteristics.

How Buyers Rate Mysoline

Based on 5 reviews

Andrew, 37 Verified
Rating: 5 out of 5

I took Mysoline for focal seizures for several months. The first week brought heavy sleepiness and I felt unsteady getting out of bed. That eased after the gradual adjustment, and my seizure diary showed fewer episodes.

Several months 8 Nov 2026
Martin D., 52 Verified
Rating: 3.5 out of 5

The tablets helped reduce my nighttime seizures, but concentration was difficult during the first month. I stopped driving temporarily and arranged a dose review rather than changing it myself.

The first month 14 Nov 2026
Lee N., 41 Verified
Rating: 3.5 out of 5

I had been taking the prescribed dose consistently for weeks when dizziness appeared after another sedating medicine was added. The combination was changed, and the balance problem improved.

Weeks 18 Oct 2026
Darren, 34 Verified
Rating: 5 out of 5

Mysoline reduced the staring spells, although nausea bothered me at first. Taking the tablet with food made the early treatment period easier.

The early treatment period 24 Oct 2026
Gary, 44 Verified
Rating: 3.5 out of 5

I missed doses during a trip and had a breakthrough seizure. The medicine had worked well when taken regularly, so I now keep the dosing times in my phone and plan travel around them.

31 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 494 reviews Install